Invenomic Capital Management’s GrafTech EAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-99,312
Closed -$673K 127
2026
Q1
$673K Sell
99,312
-6,368
-6% -$67.3K 0.03% 144
2025
Q4
$1.64M Sell
105,680
-1,355
-1% -$20.6K 0.08% 136
2025
Q3
$1.37M Sell
107,035
-3,997
-4% -$46.3K 0.07% 138
2025
Q2
$1.08M Sell
111,032
-14,157
-11% -$125K 0.06% 141
2025
Q1
$1.09M Sell
125,189
-18,252
-13% -$237K 0.06% 163
2024
Q4
$2.48M Sell
143,441
-22,587
-14% -$421K 0.12% 143
2024
Q3
$2.19M Sell
166,028
-32,267
-16% -$269K 0.12% 133
2024
Q2
$1.92M Buy
198,295
+52,653
+36% +$810K 0.09% 148
2024
Q1
$2.01M Buy
145,642
+68,760
+89% +$1.07M 0.11% 128
2023
Q4
$1.68M Buy
+76,882
New +$2.17M 0.08% 148

Other funds holding EAF

Invenomic Capital Management's EAF Position: Q2 2026 in Review

Invenomic Capital Management sold out of GrafTech (EAF) in Q2 2026, closing a stake of 99,312 shares — an estimated $673K sold.

Invenomic Capital Management first reported a position in EAF in Q4 2023 and held it in 10 quarters. The position peaked at $2.48M in Q4 2024. 88 funds tracked by Wall St. Rank hold EAF as of Q2 2026.

  • Invenomic Capital Management reported no remaining GrafTech position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 99,312 GrafTech shares in Q2 2026, an estimated $673K.
  • Invenomic Capital Management first reported a position in GrafTech in Q4 2023 and held it in 10 quarters.
  • Invenomic Capital Management's GrafTech position peaked at $2.48M in Q4 2024.
  • 88 funds tracked by Wall St. Rank held GrafTech as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.